Thrombotic Microangiopathy, Podocytopathy, and Damage to the Renal Tubules with Severe Proteinuria and Acute Renal Dysfunction Induced by Lenvatinib.

MLA

Saki Nakashima, et al. “Thrombotic Microangiopathy, Podocytopathy, and Damage to the Renal Tubules with Severe Proteinuria and Acute Renal Dysfunction Induced by Lenvatinib.” Internal Medicine, vol. 61, no. 20, Oct. 2022, pp. 3083–88. EBSCOhost, https://doi.org/10.2169/internalmedicine.8365-21.

APA

Saki Nakashima, Akinari Sekine, Naoki Sawa, Yusuke Kawamura, Kei Kono, Keiichi Kinowaki, Masahiro Kawada, Eiko Hasegawa, Norio Akuta, Yoshiyuki Suzuki, Kenichi Ohashi, Kenmei Takaichi, Yoshifumi Ubara, & Junichi Hoshino. (2022). Thrombotic Microangiopathy, Podocytopathy, and Damage to the Renal Tubules with Severe Proteinuria and Acute Renal Dysfunction Induced by Lenvatinib. Internal Medicine, 61(20), 3083–3088. https://doi.org/10.2169/internalmedicine.8365-21

Chicago

Saki Nakashima, Akinari Sekine, Naoki Sawa, Yusuke Kawamura, Kei Kono, Keiichi Kinowaki, Masahiro Kawada, et al. 2022. “Thrombotic Microangiopathy, Podocytopathy, and Damage to the Renal Tubules with Severe Proteinuria and Acute Renal Dysfunction Induced by Lenvatinib.” Internal Medicine 61 (20): 3083–88. doi:10.2169/internalmedicine.8365-21.